Land: USA
Sprog: engelsk
Kilde: NLM (National Library of Medicine)
Nifedipine (UNII: I9ZF7L6G2L) (Nifedipine - UNII:I9ZF7L6G2L)
TEVA PHARMACEUTICALS USA
Nifedipine
Nifedipine 60 mg
PRESCRIPTION DRUG
Abbreviated New Drug Application
NIFEDIPINE- NIFEDIPINE TABLET, EXTENDED RELEASE TEVA PHARMACEUTICALS USA ---------- NIFEDIPINE EXTENDED-RELEASE TABLETS, USP 60 MG Rx only For Oral Use DESCRIPTION Nifedipine extended-release tablets are an extended release tablet dosage form of the calcium channel blocker nifedipine. Nifedipine is 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4- (2_-_nitrophenyl)-, dimethyl ester. The molecular formula is C H N O and has the structural formula: Nifedipine is a yellow crystalline substance, practically insoluble in water but soluble in ethanol. It has a molecular weight of 346.3. Nifedipine extended-release tablets contain 60 mg of nifedipine for once- a-day oral administration. In addition, each tablet contains the following inactive ingredients: anhydrous lactose, ethylcellulose, hydroxyethyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyacrylic dispersion (copolymer of ethyl acrylate and methyl methacrylate), polyethylene glycol, silicon dioxide, sodium lauryl sulfate, talc, titanium dioxide, and yellow 10 ferric oxide. Nifedipine extended-release tablets meet USP Dissolution Test 4. CLINICAL PHARMACOLOGY Nifedipine is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) which inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. The contractile processes of vascular smooth muscle and cardiac muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels. Nifedipine selectively inhibits calcium ion influx across the cell membrane of vascular smooth muscle and cardiac muscle without altering serum calcium concentrations. MECHANISM OF ACTION 17 18 2 6 The mechanism by which nifedipine reduces arterial blood pressure involves peripheral arterial vasodilatation and, consequently, a reduction in peripheral vascular resistance. The increased peripheral vascular resistance, an underlying cause of hypertension, results from an increase in active tension in Læs hele dokumentet